NDC 62756-460 – Buprenorphine

Buprenorphine Hydrochloride 8 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII 1 recall

Product NDC62756-460

Product details

Brand name
Buprenorphine
Generic name
Buprenorphine
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA201760
Marketed since
February 17, 2016
Listing expires
December 31, 2027
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine →

Package NDC codes (2)

Package NDCDescriptionSince
62756-460-643 BLISTER PACK in 1 CARTON (62756-460-64) / 10 TABLET in 1 BLISTER PACKFeb 17, 2016
62756-460-8330 TABLET in 1 BOTTLE (62756-460-83)Feb 17, 2016

Recalls mentioning this NDC

Other Buprenorphine products